T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Green Plains
GPRE
$1.09B
| $142K | ﹤0.01% |
10,833
+77
| +0.7% | +$1.26K |
|
2452
Protagonist Therapeutics
PTGX
$9.92B
| $142K | ﹤0.01% |
21,100
+4,600
| +28% | +$36.5K |
|
|
INFI
2453
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $142K | ﹤0.01% |
120,206
| – | – |
|
2454
Inseego
INSG
$77.5M
| $140K | ﹤0.01% |
3,380
| – | – |
|
|
DALN
2455
DELISTED
DallasNews
DALN
| $138K | ﹤0.01% |
10,265
+393
| +4% | +$6.85K |
|
|
FIT
2456
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $138K | ﹤0.01% |
27,848
+439
| +2% | +$2.27K |
|
|
HK
2457
DELISTED
Halcon Resources Corporation
HK
| $138K | ﹤0.01% |
81,003
+43,013
| +113% | +$135K |
|
2458
NeoGenomics
NEO
$2.11B
| $137K | ﹤0.01% |
10,857
+108
| +1% | +$1.61K |
|
2459
Accuray
ARAY
$33.3M
| $136K | ﹤0.01% |
40,024
+152
| +0.4% | +$616 |
|
|
JCP
2460
DELISTED
J.C. Penney Company, Inc.
JCP
| $133K | ﹤0.01% |
128,125
-193,580
| -60% | -$271K |
|
2461
Hovnanian Enterprises
HOV
$793M
| $128K | ﹤0.01% |
7,507
-3,263
| -30% | -$103K |
|
2462
Lightpath Technologies
LPTH
$836M
| $128K | ﹤0.01% |
86,000
+23,200
| +37% | +$40.9K |
|
2463
United Natural Foods
UNFI
$2.91B
| $126K | ﹤0.01% |
11,861
-4,614
| -28% | -$97K |
|
|
FNJN
2464
DELISTED
Finjan Holdings, Inc.
FNJN
| $126K | ﹤0.01% |
50,050
+3,600
| +8% | +$12K |
|
2465
Amkor Technology
AMKR
$14.5B
| $125K | ﹤0.01% |
19,016
+276
| +1% | +$1.82K |
|
|
SNR
2466
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $125K | ﹤0.01% |
30,258
-54,696
| -64% | -$288K |
|
|
ARC
2467
DELISTED
ARC Document Solutions, Inc.
ARC
| $124K | ﹤0.01% |
60,563
+5,400
| +10% | +$13.2K |
|
|
SELF
2468
Global Self Storage
SELF
$59M
| $123K | ﹤0.01% |
31,400
| – | – |
|
2469
Option Care Health
OPCH
$3.6B
| $122K | ﹤0.01% |
8,548
+62
| +0.7% | +$818 |
|
|
ZYNE
2470
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $122K | ﹤0.01% |
41,200
-30,400
| -42% | -$166K |
|
2471
Digi International
DGII
$3.23B
| $120K | ﹤0.01% |
11,909
-14
| -0.1% | -$162 |
|
2472
FreightCar America
RAIL
$244M
| $115K | ﹤0.01% |
17,254
| – | – |
|
|
BRS
2473
DELISTED
Bristow Group, Inc.
BRS
| $115K | ﹤0.01% |
47,252
+36,868
| +355% | +$279K |
|
2474
Everspin Technologies
MRAM
$420M
| $114K | ﹤0.01% |
20,300
| – | – |
|
2475
Kinross Gold
KGC
$31.6B
| $113K | ﹤0.01% |
35,000
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.